| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Chain A, Ferritin light chain | 3 | 0 | 0 | 3 |
| thioredoxin reductase | 7 | 0 | 0 | 7 |
| TDP1 protein | 18 | 0 | 0 | 18 |
| Microtubule-associated protein tau | 6 | 0 | 0 | 6 |
| Smad3 | 4 | 0 | 0 | 4 |
| aldehyde dehydrogenase 1 family, member A1 | 13 | 0 | 0 | 13 |
| alpha-galactosidase | 1 | 0 | 0 | 1 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 2 | 0 | 0 | 2 |
| flap endonuclease 1 | 3 | 0 | 0 | 3 |
| DNA polymerase iota isoform a (long) | 6 | 0 | 0 | 6 |
| DNA topoisomerase 2-alpha | 0 | 0 | 0 | 1 |
| Acetylcholinesterase | 0 | 2 | 0 | 2 |
| Chain A, Hyaluronidase, phage associated | 0 | 1 | 0 | 1 |
| acetylcholinesterase | 6 | 0 | 0 | 6 |
| RAR-related orphan receptor gamma | 15 | 0 | 0 | 15 |
| GLI family zinc finger 3 | 19 | 0 | 0 | 19 |
| AR protein | 21 | 0 | 0 | 21 |
| thioredoxin glutathione reductase | 5 | 0 | 0 | 5 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 12 | 0 | 0 | 12 |
| glucocorticoid receptor [Homo sapiens] | 19 | 0 | 0 | 19 |
| retinoic acid nuclear receptor alpha variant 1 | 19 | 0 | 0 | 19 |
| estrogen-related nuclear receptor alpha | 18 | 0 | 0 | 18 |
| estrogen nuclear receptor alpha | 25 | 0 | 0 | 25 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 14 | 0 | 0 | 14 |
| IDH1 | 4 | 0 | 0 | 4 |
| euchromatic histone-lysine N-methyltransferase 2 | 8 | 0 | 0 | 8 |
| chromobox protein homolog 1 | 9 | 0 | 0 | 9 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 5 | 0 | 0 | 5 |
| thyroid hormone receptor beta isoform 2 | 17 | 0 | 0 | 17 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 19 | 0 | 0 | 19 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
| geminin | 16 | 0 | 0 | 16 |
| lethal factor (plasmid) | 3 | 0 | 0 | 3 |
| lamin isoform A-delta10 | 8 | 0 | 0 | 8 |
| Polyphenol oxidase 2 | 0 | 1 | 0 | 1 |
| Pancreatic alpha-amylase | 0 | 2 | 0 | 2 |
| Albumin | 0 | 1 | 0 | 1 |
| Urease | 0 | 1 | 0 | 1 |
| Prolyl 4-hydroxylase subunit alpha-1 | 0 | 0 | 0 | 1 |
| Tyrosinase | 0 | 1 | 0 | 1 |
| Alpha-2B adrenergic receptor | 0 | 2 | 1 | 3 |
| Spike glycoprotein | 4 | 0 | 0 | 4 |
| Hyaluronate lyase | 0 | 1 | 0 | 1 |
| Prolyl hydroxylase EGLN2 | 0 | 0 | 0 | 1 |
| Egl nine homolog 1 | 0 | 0 | 0 | 1 |
| Prolyl hydroxylase EGLN3 | 0 | 0 | 0 | 1 |
| Hypoxia-inducible factor 1-alpha inhibitor | 0 | 0 | 0 | 1 |
| Solute carrier family 23 member 1 | 0 | 1 | 0 | 1 |
| interleukin 8 | 3 | 0 | 0 | 3 |
| EWS/FLI fusion protein | 4 | 0 | 0 | 4 |
| farnesoid X nuclear receptor | 7 | 0 | 0 | 7 |
| pregnane X nuclear receptor | 18 | 0 | 0 | 18 |
| G | 9 | 0 | 0 | 9 |
| cytochrome P450 2D6 | 5 | 0 | 0 | 5 |
| peroxisome proliferator activated receptor gamma | 12 | 0 | 0 | 12 |
| aryl hydrocarbon receptor | 6 | 0 | 0 | 6 |
| activating transcription factor 6 | 7 | 0 | 0 | 7 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 10 | 0 | 0 | 10 |
| heat shock protein beta-1 | 6 | 0 | 0 | 6 |
| streptokinase A precursor | 0 | 0 | 2 | 2 |
| Dihydroxyacetone phosphate acyltransferase | 0 | 0 | 0 | 2 |
| ATP-binding cassette sub-family C member 3 | 0 | 7 | 0 | 7 |
| Multidrug resistance-associated protein 4 | 0 | 7 | 0 | 7 |
| Bile salt export pump | 0 | 15 | 0 | 15 |
| Interferon beta | 11 | 0 | 0 | 11 |
| HLA class I histocompatibility antigen, B alpha chain | 9 | 0 | 0 | 9 |
| 30S ribosomal protein S6 | 0 | 4 | 1 | 5 |
| 30S ribosomal protein S7 | 0 | 4 | 1 | 5 |
| 50S ribosomal protein L15 | 0 | 4 | 1 | 5 |
| Cellular tumor antigen p53 | 12 | 0 | 0 | 12 |
| Cytochrome P450 3A4 | 0 | 3 | 0 | 3 |
| 50S ribosomal protein L10 | 0 | 4 | 1 | 5 |
| 50S ribosomal protein L11 | 0 | 4 | 1 | 5 |
| 50S ribosomal protein L7/L12 | 0 | 4 | 1 | 5 |
| 50S ribosomal protein L19 | 0 | 4 | 1 | 5 |
| 50S ribosomal protein L1 | 0 | 4 | 1 | 5 |
| 50S ribosomal protein L20 | 0 | 4 | 1 | 5 |
| 50S ribosomal protein L27 | 0 | 4 | 1 | 5 |
| 50S ribosomal protein L28 | 0 | 4 | 1 | 5 |
| 50S ribosomal protein L29 | 0 | 4 | 1 | 5 |
| 50S ribosomal protein L31 | 0 | 4 | 1 | 5 |
| 50S ribosomal protein L31 type B | 0 | 4 | 1 | 5 |
| 50S ribosomal protein L32 | 0 | 4 | 1 | 5 |
| 50S ribosomal protein L33 | 0 | 4 | 1 | 5 |
| 50S ribosomal protein L34 | 0 | 4 | 1 | 5 |
| 50S ribosomal protein L35 | 0 | 4 | 1 | 5 |
| 50S ribosomal protein L36 | 0 | 4 | 1 | 5 |
| 30S ribosomal protein S10 | 0 | 4 | 1 | 5 |
| 30S ribosomal protein S11 | 0 | 4 | 1 | 5 |
| 30S ribosomal protein S12 | 0 | 4 | 1 | 5 |
| 30S ribosomal protein S13 | 0 | 4 | 1 | 5 |
| 30S ribosomal protein S16 | 0 | 4 | 1 | 5 |
| 30S ribosomal protein S18 | 0 | 4 | 1 | 5 |
| 30S ribosomal protein S19 | 0 | 4 | 1 | 5 |
| 30S ribosomal protein S20 | 0 | 4 | 1 | 5 |
| 30S ribosomal protein S2 | 0 | 4 | 1 | 5 |
| 30S ribosomal protein S3 | 0 | 4 | 1 | 5 |
| 30S ribosomal protein S4 | 0 | 4 | 1 | 5 |
| 30S ribosomal protein S5 | 0 | 4 | 1 | 5 |
| 30S ribosomal protein S8 | 0 | 4 | 1 | 5 |
| 30S ribosomal protein S9 | 0 | 4 | 1 | 5 |
| 50S ribosomal protein L13 | 0 | 4 | 1 | 5 |
| 50S ribosomal protein L14 | 0 | 4 | 1 | 5 |
| 50S ribosomal protein L16 | 0 | 4 | 1 | 5 |
| 50S ribosomal protein L23 | 0 | 4 | 1 | 5 |
| 30S ribosomal protein S15 | 0 | 4 | 1 | 5 |
| 50S ribosomal protein L17 | 0 | 4 | 1 | 5 |
| 50S ribosomal protein L21 | 0 | 4 | 1 | 5 |
| 50S ribosomal protein L30 | 0 | 4 | 1 | 5 |
| 50S ribosomal protein L6 | 0 | 4 | 1 | 5 |
| 30S ribosomal protein S14 | 0 | 4 | 1 | 5 |
| 30S ribosomal protein S17 | 0 | 4 | 1 | 5 |
| 30S ribosomal protein S1 | 0 | 4 | 1 | 5 |
| 50S ribosomal protein L18 | 0 | 4 | 1 | 5 |
| 50S ribosomal protein L2 | 0 | 4 | 1 | 5 |
| 50S ribosomal protein L3 | 0 | 4 | 1 | 5 |
| 50S ribosomal protein L24 | 0 | 4 | 1 | 5 |
| 50S ribosomal protein L4 | 0 | 4 | 1 | 5 |
| 50S ribosomal protein L22 | 0 | 4 | 1 | 5 |
| 50S ribosomal protein L5 | 0 | 4 | 1 | 5 |
| 30S ribosomal protein S21 | 0 | 4 | 1 | 5 |
| 50S ribosomal protein L25 | 0 | 4 | 1 | 5 |
| 50S ribosomal protein L36 2 | 0 | 4 | 1 | 5 |
| Inositol hexakisphosphate kinase 1 | 9 | 0 | 0 | 9 |
| Methionine--tRNA ligase, mitochondrial | 0 | 0 | 1 | 1 |
| cytochrome P450 2C9, partial | 9 | 0 | 0 | 9 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 4 | 0 | 0 | 4 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 3 | 0 | 0 | 3 |
| Chain A, Cruzipain | 1 | 0 | 0 | 1 |
| SMAD family member 2 | 4 | 0 | 0 | 4 |
| ATAD5 protein, partial | 4 | 0 | 0 | 4 |
| SMAD family member 3 | 4 | 0 | 0 | 4 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 4 | 0 | 0 | 4 |
| nuclear receptor subfamily 1, group I, member 3 | 10 | 0 | 0 | 10 |
| progesterone receptor | 16 | 0 | 0 | 16 |
| retinoid X nuclear receptor alpha | 13 | 0 | 0 | 13 |
| bromodomain adjacent to zinc finger domain 2B | 3 | 0 | 0 | 3 |
| peroxisome proliferator-activated receptor delta | 9 | 0 | 0 | 9 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 11 | 0 | 0 | 11 |
| thyroid stimulating hormone receptor | 7 | 0 | 0 | 7 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 13 | 0 | 0 | 13 |
| nuclear receptor subfamily 1, group I, member 2 | 2 | 0 | 0 | 2 |
| vitamin D3 receptor isoform VDRA | 6 | 0 | 0 | 6 |
| thyroid hormone receptor beta isoform a | 8 | 0 | 0 | 8 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 4 | 0 | 0 | 4 |
| transcriptional regulator ERG isoform 3 | 5 | 0 | 0 | 5 |
| importin subunit beta-1 isoform 1 | 4 | 0 | 0 | 4 |
| mitogen-activated protein kinase 1 | 3 | 0 | 0 | 3 |
| snurportin-1 | 4 | 0 | 0 | 4 |
| peripheral myelin protein 22 | 5 | 0 | 0 | 5 |
| survival motor neuron protein isoform d | 6 | 0 | 0 | 6 |
| neuropeptide S receptor isoform A | 2 | 0 | 0 | 2 |
| Voltage-dependent calcium channel gamma-2 subunit | 9 | 0 | 0 | 9 |
| Glucocorticoid receptor | 0 | 16 | 2 | 23 |
| Glycine receptor subunit alpha-1 | 0 | 16 | 0 | 16 |
| Androgen receptor | 0 | 17 | 0 | 17 |
| Glutamate receptor 2 | 9 | 0 | 0 | 9 |
| Glycine receptor subunit beta | 0 | 16 | 0 | 16 |
| Glycine receptor subunit alpha-2 | 0 | 16 | 0 | 16 |
| Glycine receptor subunit alpha-3 | 0 | 16 | 0 | 16 |
| Cytochrome P450 2C19 | 0 | 1 | 0 | 1 |
| Nrf2 | 1 | 0 | 0 | 1 |
| glp-1 receptor, partial | 3 | 0 | 0 | 3 |
| GLS protein | 4 | 0 | 0 | 4 |
| apical membrane antigen 1, AMA1 | 2 | 0 | 0 | 2 |
| 67.9K protein | 3 | 0 | 0 | 3 |
| LAP4 | 0 | 0 | 1 | 1 |
| RPL19A | 0 | 0 | 1 | 1 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 2 | 0 | 0 | 2 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 2 | 0 | 0 | 2 |
| nuclear receptor ROR-gamma isoform 1 | 5 | 0 | 0 | 5 |
| Vpr | 2 | 0 | 0 | 2 |
| DNA dC->dU-editing enzyme APOBEC-3F isoform a | 1 | 0 | 0 | 1 |
| Glycoprotein hormones alpha chain | 1 | 0 | 0 | 1 |
| Botulinum neurotoxin type A | 0 | 1 | 0 | 1 |
| TAR DNA-binding protein 43 | 7 | 0 | 0 | 7 |
| ATPase family AAA domain-containing protein 5 | 4 | 0 | 0 | 4 |
| Ataxin-2 | 4 | 0 | 0 | 4 |
| DNA polymerase kappa isoform 1 | 3 | 0 | 0 | 3 |
| Chain A, HADH2 protein | 4 | 0 | 0 | 4 |
| Chain B, HADH2 protein | 4 | 0 | 0 | 4 |
| endonuclease IV | 2 | 0 | 0 | 2 |
| dopamine D1 receptor | 1 | 0 | 0 | 1 |
| pregnane X receptor | 4 | 0 | 0 | 4 |
| regulator of G-protein signaling 4 | 3 | 0 | 0 | 3 |
| peripheral myelin protein 22 isoform 1 | 2 | 0 | 0 | 2 |
| atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
| cytochrome P450 3A4 isoform 1 | 5 | 0 | 0 | 5 |
| M-phase phosphoprotein 8 | 1 | 0 | 0 | 1 |
| muscarinic acetylcholine receptor M1 | 2 | 0 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit pi | 5 | 0 | 0 | 5 |
| Sex hormone-binding globulin | 0 | 0 | 6 | 6 |
| Corticosteroid-binding globulin | 0 | 5 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit delta | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 5 | 0 | 0 | 5 |
| Potassium voltage-gated channel subfamily A member 1 | 0 | 0 | 1 | 1 |
| GABA theta subunit | 5 | 0 | 0 | 5 |
| Multidrug and toxin extrusion protein 1 | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit epsilon | 5 | 0 | 0 | 5 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 2 | 0 | 0 | 2 |
| Luciferase | 4 | 0 | 0 | 4 |
| 15-lipoxygenase, partial | 1 | 0 | 0 | 1 |
| hypoxia-inducible factor 1 alpha subunit | 7 | 0 | 0 | 7 |
| USP1 protein, partial | 5 | 0 | 0 | 5 |
| thyroid stimulating hormone receptor | 5 | 0 | 0 | 5 |
| estrogen receptor 2 (ER beta) | 12 | 0 | 0 | 12 |
| Histone H2A.x | 10 | 0 | 0 | 10 |
| cellular tumor antigen p53 isoform a | 3 | 0 | 0 | 3 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 1 | 0 | 0 | 1 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 2 | 0 | 0 | 2 |
| serine/threonine-protein kinase PLK1 | 3 | 0 | 0 | 3 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
| high affinity choline transporter 1 isoform a | 0 | 1 | 0 | 1 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 2 | 0 | 0 | 2 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 1 | 0 | 4 | 0 | 4 |
| Carbonic anhydrase 2 | 0 | 4 | 0 | 4 |
| Estrogen receptor | 0 | 12 | 3 | 16 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 1 | 0 | 1 |
| Integrin beta-3 | 3 | 0 | 0 | 3 |
| Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 6 | 0 | 6 |
| Integrin alpha-IIb | 3 | 0 | 0 | 3 |
| Beta-1 adrenergic receptor | 0 | 2 | 0 | 2 |
| Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
| Adenosine receptor A3 | 0 | 4 | 0 | 4 |
| Muscarinic acetylcholine receptor M1 | 0 | 2 | 0 | 2 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 4 | 0 | 4 |
| D(2) dopamine receptor | 0 | 2 | 0 | 2 |
| Alpha-1B adrenergic receptor | 0 | 5 | 0 | 5 |
| Alpha-2C adrenergic receptor | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 2 |
| Substance-K receptor | 0 | 2 | 0 | 2 |
| D(1A) dopamine receptor | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Sodium-dependent noradrenaline transporter | 0 | 6 | 0 | 6 |
| Thromboxane-A synthase | 0 | 1 | 0 | 1 |
| Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
| Adenosine receptor A2a | 0 | 4 | 0 | 4 |
| Adenosine receptor A1 | 0 | 2 | 0 | 2 |
| Sodium-dependent serotonin transporter | 0 | 10 | 0 | 10 |
| Mu-type opioid receptor | 0 | 4 | 0 | 4 |
| D(3) dopamine receptor | 0 | 2 | 0 | 2 |
| Vasopressin V1a receptor | 0 | 2 | 0 | 2 |
| Alpha-synuclein | 1 | 3 | 0 | 4 |
| Delta-type opioid receptor | 0 | 2 | 0 | 2 |
| Kappa-type opioid receptor | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 2B | 0 | 4 | 0 | 4 |
| Alpha-1A adrenergic receptor | 0 | 5 | 0 | 5 |
| Histamine H2 receptor | 1 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 6 | 0 | 2 | 0 | 2 |
| Nuclear receptor ROR-gamma | 5 | 0 | 0 | 5 |
| Estrogen-related receptor gamma | 0 | 0 | 1 | 1 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 1 | 0 | 0 | 1 |
| Inositol monophosphatase 1 | 2 | 0 | 0 | 2 |
| Sodium-dependent dopamine transporter | 0 | 4 | 0 | 4 |
| Aldehyde oxidase | 0 | 2 | 0 | 2 |
| UDP-glucose 4-epimerase | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
| Estrogen receptor beta | 0 | 6 | 3 | 10 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 2 | 0 | 2 |
| Cysteinyl leukotriene receptor 1 | 0 | 2 | 0 | 2 |
| Cereblon isoform 4 | 0 | 2 | 0 | 2 |
| Insulin-like growth factor-binding protein 5 | 0 | 0 | 1 | 1 |
| Choline O-acetyltransferase | 0 | 1 | 0 | 1 |
| Protein cereblon | 0 | 2 | 0 | 2 |
| Chain A, Beta-lactamase | 3 | 0 | 0 | 3 |
| Motilin receptor | 0 | 0 | 1 | 1 |
| acid sphingomyelinase | 1 | 0 | 0 | 1 |
| low molecular weight phosphotyrosine protein phosphatase isoform c | 0 | 1 | 0 | 1 |
| Motilin receptor | 0 | 1 | 1 | 2 |
| Rap guanine nucleotide exchange factor 3 | 4 | 0 | 0 | 4 |
| Albumin | 0 | 0 | 1 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
| 60 kDa chaperonin | 0 | 1 | 0 | 1 |
| 60 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C9 | 0 | 2 | 0 | 2 |
| Chitinase B | 0 | 1 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
| Low molecular weight phosphotyrosine protein phosphatase | 0 | 1 | 0 | 1 |
| Cytochrome P450 2J2 | 0 | 2 | 0 | 2 |
| 10 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 1 | 0 | 1 |
| Cytochrome P450 1B1 | 0 | 2 | 0 | 2 |
| Thiosulfate sulfurtransferase | 0 | 1 | 0 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 2 | 0 | 2 |
| 60 kDa chaperonin | 0 | 1 | 0 | 1 |
| 10 kDa chaperonin | 0 | 1 | 0 | 1 |
| Canalicular multispecific organic anion transporter 1 | 0 | 6 | 0 | 6 |
| UDP-glucuronosyltransferase 2B7 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A1 | 0 | 2 | 0 | 2 |
| Lanosterol 14-alpha demethylase | 0 | 0 | 1 | 1 |
| Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
| UDP-glucuronosyltransferase 1A10 | 0 | 0 | 0 | 1 |
| NFKB1 protein, partial | 1 | 0 | 0 | 1 |
| GALC protein | 2 | 0 | 0 | 2 |
| nonstructural protein 1 | 1 | 0 | 0 | 1 |
| arylsulfatase A | 1 | 0 | 0 | 1 |
| Bloom syndrome protein isoform 1 | 1 | 0 | 0 | 1 |
| hexokinase-4 isoform 1 | 1 | 0 | 0 | 1 |
| glucokinase regulatory protein | 1 | 0 | 0 | 1 |
| urokinase-type plasminogen activator precursor | 5 | 0 | 0 | 5 |
| plasminogen precursor | 5 | 0 | 0 | 5 |
| urokinase plasminogen activator surface receptor precursor | 5 | 0 | 0 | 5 |
| Steryl-sulfatase | 0 | 1 | 0 | 1 |
| Aromatase | 0 | 1 | 0 | 1 |
| 17-beta-hydroxysteroid dehydrogenase type 1 | 0 | 2 | 0 | 3 |
| Mu-type opioid receptor | 0 | 0 | 1 | 1 |
| Mu-type opioid receptor | 0 | 0 | 1 | 1 |
| Ghrelin O-acyltransferase | 0 | 1 | 0 | 1 |
| Fumarate hydratase | 1 | 0 | 0 | 1 |
| PPM1D protein | 1 | 0 | 0 | 1 |
| caspase 7, apoptosis-related cysteine protease | 1 | 0 | 0 | 1 |
| polyprotein | 1 | 0 | 0 | 1 |
| caspase-3 | 1 | 0 | 0 | 1 |
| lysosomal alpha-glucosidase preproprotein | 2 | 0 | 0 | 2 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2B1 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-4 | 2 | 0 | 0 | 2 |
| Neuronal acetylcholine receptor subunit beta-2 | 2 | 0 | 0 | 2 |
| Cytochrome P450 2B6 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 2 |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0 | 1 | 0 | 1 |
| Sulfotransferase 1A1 | 0 | 2 | 1 | 4 |
| Nuclear receptor subfamily 1 group I member 3 | 0 | 1 | 0 | 1 |
| Multidrug and toxin extrusion protein 2 | 0 | 1 | 0 | 1 |
| ATP-dependent phosphofructokinase | 1 | 0 | 0 | 1 |
| Menin | 0 | 0 | 1 | 1 |
| Lecithin retinol acyltransferase | 0 | 1 | 0 | 1 |
| Lethal factor | 0 | 1 | 0 | 1 |
| Protein Rev | 0 | 0 | 1 | 1 |
| Aminoglycoside 3'-phosphotransferase | 0 | 0 | 0 | 1 |
| Tyrosyl-DNA phosphodiesterase 1 | 0 | 1 | 0 | 1 |
| histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
| Carbonic anhydrase 4 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 15 | 0 | 2 | 0 | 2 |
| DNA polymerase beta | 2 | 0 | 0 | 2 |
| Progesterone receptor | 0 | 3 | 2 | 6 |
| cystic fibrosis transmembrane conductance regulator ATP-binding cassette sub-family C member 7 | 0 | 0 | 0 | 1 |
| histone acetyltransferase KAT2A isoform 1 | 4 | 0 | 0 | 4 |
| Cannabinoid receptor 1 | 0 | 2 | 0 | 2 |
| glucocerebrosidase | 2 | 0 | 0 | 2 |
| phosphopantetheinyl transferase | 2 | 0 | 0 | 2 |
| Thioredoxin reductase | 0 | 1 | 0 | 1 |
| muscleblind-like protein 1 isoform 1 | 2 | 0 | 0 | 2 |
| Flavodoxin | 0 | 0 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 1 | 0 | 2 | 0 | 3 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial | 0 | 1 | 0 | 1 |
| [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial | 0 | 1 | 0 | 1 |
| [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial | 0 | 1 | 0 | 1 |
| [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial | 0 | 1 | 0 | 1 |
| Sodium/iodide cotransporter | 0 | 1 | 0 | 1 |
| Chain A, 2-oxoglutarate Oxygenase | 2 | 0 | 0 | 2 |
| Metabotropic glutamate receptor 5 | 0 | 1 | 0 | 1 |
| Snake venom metalloproteinase BaP1 | 0 | 1 | 0 | 1 |
| NAD(+) hydrolase SARM1 | 0 | 2 | 0 | 2 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 2 | 0 | 0 | 2 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
| WRN | 1 | 0 | 0 | 1 |
| Valosin-containing protein | 0 | 1 | 0 | 1 |
| microphthalmia-associated transcription factor isoform 9 | 0 | 1 | 0 | 1 |
| eukaryotic translation initiation factor 4 gamma 1 isoform 4 | 0 | 1 | 0 | 1 |
| DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
| eukaryotic translation initiation factor 4E isoform 1 | 0 | 1 | 0 | 1 |
| Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
| phosphoglycerate kinase | 1 | 0 | 0 | 1 |
| Type II pantothenate kinase | 0 | 0 | 0 | 1 |
| Type III pantothenate kinase | 0 | 0 | 0 | 1 |
| luciferase | 0 | 0 | 0 | 1 |
| Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
| Glucocorticoid receptor | 0 | 1 | 1 | 2 |
| Glucocorticoid receptor | 0 | 0 | 1 | 1 |
| Mineralocorticoid receptor | 0 | 2 | 1 | 3 |
| Androgen receptor | 0 | 2 | 0 | 2 |
| Glutamine synthetase | 0 | 0 | 1 | 1 |
| Histamine H1 receptor | 0 | 0 | 1 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Nociceptin receptor | 0 | 0 | 1 | 1 |
| cytochrome P450 2D6 isoform 1 | 1 | 0 | 0 | 1 |
| Bile salt export pump | 0 | 1 | 0 | 1 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 0 | 0 | 1 |
| Protein-arginine deiminase type-4 | 0 | 3 | 0 | 3 |
| 90-kda heat shock protein beta HSP90 beta, partial | 0 | 1 | 0 | 1 |
| estrogen receptor beta isoform 1 | 0 | 1 | 0 | 1 |
| heat shock protein HSP 90-alpha isoform 2 | 0 | 1 | 0 | 1 |
| tyrosine-protein phosphatase non-receptor type 7 isoform 2 | 0 | 1 | 0 | 1 |
| Tetracycline resistance protein, class B | 0 | 0 | 0 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 1 | 0 | 1 |
| 72 kDa type IV collagenase | 0 | 1 | 0 | 1 |
| Stromelysin-1 | 0 | 1 | 0 | 1 |
| Multidrug transporter MdfA | 0 | 1 | 0 | 1 |
| Neutrophil collagenase | 0 | 1 | 0 | 1 |
| Alpha-1D adrenergic receptor | 0 | 1 | 0 | 1 |
| Collagenase 3 | 0 | 1 | 0 | 1 |
| Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
| Integrase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 0 | 0 | 1 |
| P2Y purinoceptor 12 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 11 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
| Chain A, ykoF | 0 | 0 | 1 | 1 |
| Chain B, ykoF | 0 | 0 | 1 | 1 |
| Chain A, ThiT | 0 | 0 | 1 | 1 |
| Thiamine transporter ThiT | 0 | 0 | 1 | 1 |
| Carbonic anhydrase 6 | 0 | 1 | 0 | 1 |
| Transketolase | 0 | 0 | 1 | 1 |
| Thiamine-binding periplasmic protein | 0 | 0 | 1 | 1 |
| Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |